These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9251841)

  • 1. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus.
    Chan EY; Ko SC; Lau CS
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):3-7. PubMed ID: 9251841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study on apoptosis and expression of apoptosis-related genes in peripheral blood lymphocytes of patients with systemic lupus erythematosus].
    Xie M; Wang Z; Liu X; Qiang O; Liu G
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):192-5. PubMed ID: 12212057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
    Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
    Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.
    Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S
    Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance and expression of Bcl-2 protein in patients with systemic lupus erythematosus].
    Liu Y; Yin P; Zhao X; Shi C; Kong Q; Guan W
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):94-7. PubMed ID: 11798633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.
    Aringer M; Wintersberger W; Steiner CW; Kiener H; Presterl E; Jaeger U; Smolen JS; Graninger WB
    Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
    Emlen W; Niebur J; Kadera R
    J Immunol; 1994 Apr; 152(7):3685-92. PubMed ID: 8144943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
    Miret C; Molina R; Filella X; García-Carrasco M; Claver G; Ingelmo M; Ballesta A; Font J
    Tumour Biol; 2003; 24(4):185-8. PubMed ID: 14654712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus.
    Graninger WB
    Wien Klin Wochenschr; 1992; 104(7):205-7. PubMed ID: 1523845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
    Rose LM; Latchman DS; Isenberg DA
    Br J Rheumatol; 1995 Apr; 34(4):316-20. PubMed ID: 7788144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.